Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
March 9, 2023 - 2 minutes
funding
Ampersand Biomedicines launched to develop drugs that only work at disease sites
Flagship Pioneering has created Ampersand Biomedicines, a company creating programmable medicines that are intended to…
March 9, 2023 - 2 minutes
Noema Pharma raises $112 million in Series B financing
Noema Pharma, a Swiss clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, has…
March 8, 2023 - 2 minutes
Ten new companies join BioInnovation Institute’s Venture Lab program
BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has added…
March 2, 2023 - 3 minutes
Life changing treatments for rare disease – a beacon of hope
By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are…
February 28, 2023 - 6 minutes
Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment
Resalis Therapeutics has completed a seed financing round of €10 million to establish a non-coding…
February 24, 2023 - 2 minutes
Italian life sciences fund hits €175M
Panakès Partners, an Italian venture capital firm in the life sciences sector, has closed its…
February 23, 2023 - 3 minutes
Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders
Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding…
February 21, 2023 - 2 minutes
Maxion Therapeutics raises $16M to target GPCRs
Biotechnology company Maxion Therapeutics has completed its $16 million Series A financing. The funds will…
February 16, 2023 - 3 minutes
BiPER Therapeutics raises €1.25M to develop small molecules to treat gastrointestinal cancers
BiPER Therapeutics, a French preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to…
February 14, 2023 - 2 minutes
Icosagen receives €18M loan for R&D and new facility
The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the…
February 9, 2023 - 2 minutes
TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million…
February 9, 2023 - 2 minutes
